Chimeric antigen receptor T (CAR-T) cell therapy is an effective treatment for treatment-refractory hematological disorders with an acceptable safety profile. In contrast, preliminary reports suggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results